As shown in our study, B7-H3 is particularly suitable for CAR-T cells targeting in CRC due to its nearly 100% positive expression in tumors and the promising anti-tumor activity of B7-H3 CAR-T cells in metastatic CRC. This evidence concerns the gene CD276 and colorectal carcinoma.